Skip to main content
Pharmadrug Inc. logo

Pharmadrug Inc. — Investor Relations & Filings

Ticker · PHRX ISIN · CA71716W2040 LEI · 529900PHQPAWL5ITEB39 CSE Manufacturing
Open in API
Filings indexed 475 across all filing types
Latest filing 2020-06-02 Regulatory Filings
Country CA Canada
Listing CSE PHRX

About Pharmadrug Inc.

https://pharmadrug.ca/

Pharmadrug Inc. is a specialty pharmaceutical company focused on the research, development, and commercialization of controlled-substances and natural medicines. The company's primary focus areas include the clinical development of reformulated natural-based medicines aimed at treating unmet needs in oncology and infectious diseases. Additionally, Pharmadrug develops synthetic and biosynthetic formulations of existing drugs, specifically addressing opportunities related to the potential third wave of drug policy reform concerning controlled substances.

Recent filings

Filing Released Lang Actions
Material document(s).pdf
Regulatory Filings
2020-06-02 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of Terry Booth as Chairman of the Advisory Board of PharmaDrug Inc. It focuses on management changes and strategic expertise brought by the new appointee. There is no detailed financial data, quarterly or annual report content, or regulatory filing information. The document discusses M&A experience but does not announce a specific merger or acquisition transaction. It is primarily an announcement of a board/advisory appointment, which fits the category of Board/Management Information (MANG). The document length is 8310 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data. Therefore, the appropriate classification is MANG with high confidence.
2020-06-02 English
News release - English.pdf
Regulatory Filings
2020-05-29 English
Material change report - English.pdf
Regulatory Filings
2020-05-26 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Pharmadrug Inc. has issued an unsecured promissory note for $80,000 as part of a financing arrangement. It mentions the use of proceeds for working capital and references a definitive agreement for an acquisition. The document does not contain financial statements or detailed financial analysis, nor is it a transcript, report, or regulatory filing. It is an update on a capital raising activity and financing arrangement. The document length is 4282 characters, which is relatively short and consistent with a capital/financing update announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-05-25 English
News release - English.pdf
Regulatory Filings
2020-05-25 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.